Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA

Monday, August 24, 2026 - 13:35
0 0
Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA
Aurobindo Pharma said the US FDA conducted a routine inspection of its wholly owned step-down subsidiary in the US from 17th to 21st August 2026, which concluded with four observations.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Comments (0)

User